Sep 2, 2010	13:39	Acasti Pharma Inc. Reports Positive Impacts on Cardiometabolic Associated Disorders
		This release replaces and supersedes the press release sent earlier today. Acasti Pharma Inc., a subsidiary of Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX-V:NTB) reports significant results on the effects of its anti-dyslipidemic investigational drug candidate CaPre(tm) on C-reactive protein (CRP) levels, a biomarker of CardioVascular Disease risk (CVD) and associated with diabetes and obesity.  continued...
Sep 2, 2010	12:02	Revolutions Medical's CEO Ron Wheet Has Scheduled an Interview to Discuss Recent New Developments With the Company
		Revolutions Medical's ("Revolutions Medical" or the "Company") (OTCBB:RMCP) CEO Ron Wheet is scheduled to do an interview on Thursday, September 9th at 11:00AM EDT with www.wallstreetreporter.com. Everyone can access this interview by logging onto their website and clicking on the link next to our name. What the company hopes to accomplish with this interview is to discuss recent news and new developments and give some guidance going forward.  continued...
Sep 2, 2010	09:30	Generex Oncology Announces Consultancy of Dr. George E. Peoples, MD
		Generex Biotechnology Corporation (www.generex.com) (Nasdaq:GNBT) today announced the engagement of Dr. George E. Peoples, Jr., M.D., F.A.C.S. as a consultant to the Company in respect of the on-going clinical and regulatory work of Antigen Express, Inc. (www.antigenexpress.com), the Company's wholly-owned subsidiary, in respect of the proprietary Antigen Express AE37 immunotherapeutic breast cancer vaccine, presently in a Phase II clinical trial at The Henry M. Jackson Foundation for the Advancement of Military Medicine (www.hjf.org).  continued...
Sep 2, 2010	09:15	Myrexis to Present at Rodman & Renshaw and UBS Conferences
		Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today announced that Adrian Hobden, Ph.D., President and Chief Executive Officer, is scheduled to present an overview of the Company at two upcoming conferences in New York, NY: the Rodman & Renshaw Global Investment Conference, to be held September 12-15, 2010; and the UBS Global Life Sciences Conference, taking place September 20-22, 2010.  continued...
Sep 2, 2010	08:30	SectorWatch.biz: An Energetic Chorus of Optimism
		Despite the roller coaster economy of the past two years, the energy drink market has fared rather well according to several recent industry reports. According to a report titled Comprehensive Reviews in Food Science and Food Safety, Energy Drinks Dominate the Functional Beverage Market in the U.S. and since its introduction in 1997, the energy drink market is the fastest growing segment in the beverage industry.  continued...
Sep 2, 2010	08:00	XOMA Regains NASDAQ Compliance
		XOMA Ltd. (Nasdaq:XOMAD), a leader in the discovery and development of therapeutic antibodies, today announced that NASDAQ has notified the Company that it regained compliance with the minimum $1.00 per share bid price requirement for continued listing. Accordingly, the Company will continue to be listed on The NASDAQ Global Market.   continued...
Sep 2, 2010	07:30	Acasti Pharma Inc. Reports Positive Impacts on Obesity and Cardiometabolic Associated Disorders
		Acasti Pharma Inc., a subsidiary of Neptune Technologies & Bioressources Inc. ("Neptune") (Nasdaq:NEPT) (TSX-V:NTB) reports significant results on the effects of its anti-dyslipidemic investigational drug candidate CaPre(tm) on C-reactive protein (CRP) levels, a biomarker of CardioVascular Disease risk (CVD) and associated with diabetes and obesity.  continued...
Sep 2, 2010	07:00	Fresh Healthy Vending Franchisee to Launch Throughout Scottsdale Schools
		Fresh Healthy Vending, the leading provider of healthy vending machines and products has secured placement for their healthy vending machines on the campuses of several Scottsdale schools; offering an all-natural alternative to traditional vending products which are usually high in calories, sugars, and fats. This is yet another indication that the nationwide push for healthier foods in schools outlined under the Healthy Hunger-Free Kids Act has reached Arizona. These Arizona schools will be among the first in the state to take advantage of healthy vending machines, and their students will be the first to reap the benefits of Fresh Healthy Vending's all-natural and organic products.  continued...
Sep 2, 2010	06:43	Sinobiomed Announces New Chief Executive Officer
		The Board of Directors of Sinobiomed Inc. ("Sinobiomed", or "the Company") (Pink Sheets:SOBM) is pleased to announce the appointment of a new Chief Executive Officer.   continued...
Sep 2, 2010	06:00	MediciNova to Present at the Rodman and Renshaw Annual Global Investment Conference
		MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Hercules Market of the Osaka Securities Exchange (Code Number: 4875), today announced that Shintaro Asako, Chief Financial Officer of MediciNova, will present a company overview at the Rodman and Renshaw Annual Global Investment Conference on Monday, September 13, 2010 at 3:40 p.m. Eastern time. The conference is being held at The Palace Hotel in New York City.  continued...
Sep 2, 2010	01:46	Evotec Completes Acquisition of DeveloGen
		Evotec AG (Frankfurt:EVT) (TecDAX) today announced the Closing of the agreement to acquire DeveloGen as announced in detail on 14 July 2010.  continued...
Sep 1, 2010	18:23	OptimumCare Corporation Has a Profit of .02 Cents Per Share for the First Six Months of 2010
		OptimumCare Corporation (Pink Sheets:OPMC), a behavioral healthcare and temporary staffing services provider, today reported that the company achieved profitability in the second three months of 2010, as well as the first six months of 2010.  continued...
Sep 1, 2010	16:50	Discussions Continue on Acquisition Proposal From Onex Corporation
		ResCare, Inc. (Nasdaq:RSCR) announced that discussions between a special committee of independent ResCare directors and Onex Corporation ("Onex") are continuing as the committee evaluates the acquisition proposal from Onex announced on August 16, 2010.  continued...
Sep 1, 2010	15:52	Revolutions Medical Corporation Announces Final Vetting Process for Initial Worldwide Distributors of Its RevVac Safety Syringe
		Revolutions Medical ("Revolutions Medical" or the "Company") (OTCBB:RMCP) is entering the final stage of the process to determine its initial global distributors. Since receiving FDA clearance for its RevVac safety syringe, the Company has received numerous inquiries to distribute its product. The potential future distributors have been narrowed down to a pool of just under 50 distributors. Over the next several weeks, the Company will be sending out market samples, confirming interest and commitments, and signing distribution agreements covering certain countries and regions, as well as global licensing agreements.  continued...
Sep 1, 2010	11:59	Elite Pharmaceuticals Announces Acquisition of Generic Naltrexone Product
		Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the acquisition of a currently approved Abbreviated New Drug Application (ANDA) for naltrexone hydrochloride 50 mg tablets from Mikah Pharma LLC ("Mikah"). The brand product and its generic equivalents had annual sales of approximately $14 million in 2009 and there are currently three other approved generic manufacturers plus the innovator. The transfer of the ANDA will begin immediately and Elite expects to begin manufacture of the product early next year. Pursuant to the agreement, Elite will be entitled to sell the drug in the United States and its territories, including Puerto Rico, and has licensed to Mikah the right to sell the drug in the remainder of the world.   continued...
More >>

Total: 15

* all times are in the U.S. Eastern Time Zone